Internal Medicine, Cardiovascular Disease · Bel Air, MD
NPI
1598759326
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
520 Upper Chesapeake Dr, Suite 201
Bel Air, MD, 21014
Phone (443) 643-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$306K
10,895 services
Medicare patients, 2024
2,681
Average age 76
Drug cost, 2024
$1.6M
9,413 prescriptions
Company payments, 2025
$2,440
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David C Rubin was code 93000 (electrocardiogram), 1,306 times for 997 patients. In total David C Rubin billed 10,895 services in 34 codes, and Medicare paid $306K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 1,306 | 997 | $10.89 | $14K |
| 93010 Electrocardiogram | Facility | 1,269 | 1,009 | $6.44 | $8,173 |
| 99214 Office E&M - Established | Office | 1,240 | 943 | $91.97 | $114K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,232 | 985 | $12.58 | $16K |
| 93016 Electrocardiogram | Facility | 296 | 296 | $15.76 | $4,665 |
| 93018 Electrocardiogram | Facility | 296 | 296 | $10.47 | $3,100 |
| 99232 Hospital E&M - Subsequent | Facility | 267 | 169 | $63.54 | $17K |
| 93306 Echocardiography (TTE/TEE) | Facility | 265 | 262 | $52.30 | $14K |
| 78451 Myocardial Perfusion Scan | Facility | 219 | 219 | $48.25 | $11K |
| 99223 Hospital E&M - Initial | Facility | 184 | 179 | $135.64 | $25K |
| 99204 Office E&M - New | Office | 114 | 114 | $125.74 | $14K |
| 78452 Myocardial Perfusion Scan | Facility | 77 | 77 | $53.84 | $4,146 |
| 93306 Echocardiography (TTE/TEE) | Office | 76 | 76 | $148.95 | $11K |
| 93015 Electrocardiogram | Office | 50 | 50 | $58.71 | $2,936 |
| 93224 Electrocardiogram | Office | 43 | 41 | $52.54 | $2,259 |
By year: 2022 $275K for 6,116 services; 2023 $262K for 6,103 services; 2024 $306K for 10,895 services.
Medicare prescription drug claims, 2024
In 2024, the drug David C Rubin prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,510 prescriptions and refills. In total David C Rubin wrote 9,413 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,510 | 4,448 | 482 | $30K |
| Metoprolol Succinate Generic | 793 | 2,263 | 257 | $14K |
| Ezetimibe Generic | 741 | 2,128 | 244 | $29K |
| Atorvastatin Calcium Generic | 713 | 2,126 | 237 | $10K |
| Eliquis Apixaban | 514 | 1,176 | 141 | $669K |
| Digoxin Generic | 405 | 1,184 | 134 | $12K |
| Metoprolol Tartrate Generic | 390 | 1,159 | 129 | $3,359 |
| Clopidogrel Clopidogrel Bisulfate | 373 | 1,108 | 121 | $5,391 |
| Lisinopril Generic | 309 | 917 | 100 | $2,237 |
| Olmesartan Medoxomil Generic | 305 | 900 | 102 | $8,078 |
| Amlodipine Besylate Generic | 290 | 866 | 104 | $2,307 |
| Xarelto Rivaroxaban | 276 | 717 | 78 | $389K |
| Furosemide Generic | 266 | 758 | 107 | $1,695 |
| Losartan Potassium Generic | 241 | 709 | 94 | $2,681 |
| Doxazosin Mesylate Generic | 221 | 639 | 80 | $4,497 |
Brand drugs: 1,191 claims; generic drugs: 8,222 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David C Rubin $2,440 ($2,440 in general payments such as food, travel and fees) from 19 companies. The largest payer was AOP Health US, LLC with $560.
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $560 |
| E.R. Squibb & Sons, L.L.C. BMY | 38 | $299 |
| Scpharmaceuticals Inc. SCPH | 9 | $268 |
| Kestra Medical Technology Services, Inc. | 7 | $251 |
| Pfizer Inc. PFE | 21 | $228 |
| Alnylam Pharmaceuticals Inc. ALNY | 6 | $142 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $110 |
| Boston Scientific Corporation BSX | 3 | $103 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $81.4 |
| Esperion Therapeutics, Inc. ESPR | 3 | $59.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.